Geert Berx
Geert Berx
Verified email at dmbr.ugent.be
Title
Cited by
Cited by
Year
Regulatory networks defining EMT during cancer initiation and progression
B De Craene, G Berx
Nature Reviews Cancer 13 (2), 97-110, 2013
21682013
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion
J Comijn, G Berx, P Vermassen, K Verschueren, L van Grunsven, ...
Molecular cell 7 (6), 1267-1278, 2001
15702001
The cell-cell adhesion molecule E-cadherin
F Van Roy, G Berx
Cellular and molecular life sciences 65 (23), 3756-3788, 2008
12782008
E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
G Berx, AM Cleton‐Jansen, F Nollet, WJ De Leeuw, M Van de Vijver, ...
The EMBO journal 14 (24), 6107-6115, 1995
9091995
DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells
A Eger, K Aigner, S Sonderegger, B Dampier, S Oehler, M Schreiber, ...
Oncogene 24 (14), 2375-2385, 2005
8282005
Involvement of members of the cadherin superfamily in cancer
G Berx, F Van Roy
Cold Spring Harbor perspectives in biology 1 (6), a003129, 2009
7722009
Mutations of the human E‐cadherin (CDH1) gene
G Berx, KF Becker, H Höfler, F Van Roy
Human mutation 12 (4), 226-237, 1998
6971998
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell–cell junctions
C Vandewalle, J Comijn, B De Craene, P Vermassen, E Bruyneel, ...
Nucleic acids research 33 (20), 6566-6578, 2005
6072005
The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression
G Berx, F Van Roy
Breast Cancer Research 3 (5), 1-5, 2001
5612001
E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain.
G Berx, AM Cleton-Jansen, K Strumane, WJ De Leeuw, F Nollet, ...
Oncogene 13 (9), 1919-1925, 1996
5491996
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
J Van Deun, P Mestdagh, P Agostinis, Ö Akay, S Anand, J Anckaert, ...
Nature methods 14 (3), 228-232, 2017
5192017
A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer
S Spaderna, O Schmalhofer, F Hlubek, G Berx, A Eger, S Merkel, A Jung, ...
Gastroenterology 131 (3), 830-840, 2006
4802006
The role of the ZEB family of transcription factors in development and disease
C Vandewalle, F Van Roy, G Berx
Cellular and molecular life sciences 66 (5), 773-787, 2009
4772009
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis
CB Vos, AM Cleton-Jansen, G Berx, WJF De Leeuw, NT Ter Haar, ...
British journal of cancer 76 (9), 1131-1133, 1997
3811997
Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ
WJF de Leeuw, G Berx, CBJ Vos, JL Peterse, MJ Van de Vijver, S Litvinov, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 1997
3611997
Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1)
G Berx, K Staes, J van Hengel, F Molemans, MJG Bussemakers, ...
Genomics 26 (2), 281-289, 1995
3531995
Guidelines and definitions for research on epithelial–mesenchymal transition
J Yang, P Antin, G Berx, C Blanpain, T Brabletz, M Bronner, K Campbell, ...
Nature reviews Molecular cell biology 21 (6), 341-352, 2020
3422020
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
JC Machado, C Oliveira, R Carvalho, P Soares, G Berx, C Caldas, ...
Oncogene 20 (12), 1525-1528, 2001
3412001
Cadherins and epithelial-to-mesenchymal transition
A Gheldof, G Berx
Progress in molecular biology and translational science 116, 317-336, 2013
3202013
VHL promotes E2 box-dependent E-cadherin transcription by HIF-mediated regulation of SIP1 and snail
AJ Evans, RC Russell, O Roche, TN Burry, JE Fish, VWK Chow, WY Kim, ...
Molecular and cellular biology 27 (1), 157-169, 2007
3062007
The system can't perform the operation now. Try again later.
Articles 1–20